TLK-199

Drug name TLK-199

Brand name(s)/Manufacturer(s)
Telintra, Manufacturer: Telik, Inc.

How the Drug is Given
TLK-199 is given orally or administered by infusion.

About the Drug
TLK-199 is a small molecule drug that stimulates the bone marrow to produce blood cells. Currently TLK-199 is in Phase II of the Food and Drug Administration's (FDA's) clinical trial for the treatment of myelodsyplasitc syndromes (MDS). www.clinicaltrials.gov

Side effects
Since TLK-199 is a new drug, investigators are learning about side effects through clinical research studies. Side effects will be posted as published information becomes available.

Special concerns
Since TLK-199 is a new drug, investigators are learning about special concerns through clinical research studies. Special Concerns will be posted as published information becomes available.

More information
Current Clinical Studies
AA&MDSIF Patient Clinical Trials - www.aamds.org
ClinicalTrials.gov: TLK-199 – www.clinicaltrials.gov 

Medical Literature
Telik - TLK-199: www.telik.com